ProfileGDS4814 / ILMN_1770732
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 96% 96% 96% 96% 96% 97% 96% 96% 96% 97% 96% 95% 96% 96% 96% 96% 96% 96% 96% 96% 96% 96% 96% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)110196
GSM780708Untreated after 4 days (C2_1)1149.4196
GSM780709Untreated after 4 days (C3_1)1221.4396
GSM780719Untreated after 4 days (C1_2)1150.6796
GSM780720Untreated after 4 days (C2_2)1206.0496
GSM780721Untreated after 4 days (C3_2)1279.5697
GSM780710Trastuzumab treated after 4 days (T1_1)1235.9596
GSM780711Trastuzumab treated after 4 days (T2_1)1128.2196
GSM780712Trastuzumab treated after 4 days (T3_1)1058.5196
GSM780722Trastuzumab treated after 4 days (T1_2)1304.9997
GSM780723Trastuzumab treated after 4 days (T2_2)1144.3296
GSM780724Trastuzumab treated after 4 days (T3_2)964.18895
GSM780713Pertuzumab treated after 4 days (P1_1)1054.4596
GSM780714Pertuzumab treated after 4 days (P2_1)1220.1696
GSM780715Pertuzumab treated after 4 days (P3_1)1121.8996
GSM780725Pertuzumab treated after 4 days (P1_2)1121.3296
GSM780726Pertuzumab treated after 4 days (P2_2)1170.0396
GSM780727Pertuzumab treated after 4 days (P3_2)1204.1296
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)1158.6996
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)1201.0996
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)1120.2796
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)1076.7696
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)1045.496